Target Name: ZHX1
NCBI ID: G11244
Review Report on ZHX1 Target / Biomarker Content of Review Report on ZHX1 Target / Biomarker
ZHX1
Other Name(s): ZHX1 variant 1 | ZHX1_HUMAN | Zinc fingers and homeoboxes 1, transcript variant 1 | Zinc fingers and homeobox 1 | zinc fingers and homeoboxes 1 | Zinc finger and homeodomain protein 1 | zinc finger and homeodomain protein 1 | Zinc fingers and homeoboxes protein 1 | zinc fingers and homeobox 1 | ZHX1 variant 2 | Zinc fingers and homeoboxes 1, transcript variant 2 | Zinc-fingers and homeoboxes 1

ZHX1: A Protein Involved in Cell Signaling and Inflammation

ZHX1 (ZHX1 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidney. It is a member of the ZHX family of proteins, which are known for their role in cell signaling and inflammation. ZHX1 has been shown to play a role in the development and progression of several diseases, including neurodegenerative disorders, autoimmune diseases, and inflammation-related conditions.

One of the key functions of ZHX1 is its role in cell signaling. ZHX1 has been shown to play a role in the regulation of cell proliferation, differentiation, and survival. It has been shown to promote the growth and survival of certain cell types, while inhibiting the growth and survival of others. This suggests that ZHX1 may be a drug target or biomarker for diseases where cells are over-active or where the body is not able to control cell growth.

Another function of ZHX1 is its role in inflammation. ZHX1 has been shown to play a role in the regulation of inflammation and inflammation-related processes. It has been shown to reduce inflammation in response to certain stimuli, such as bacterial or viral infections, and to promote the recruitment of immune cells to the site of inflammation. This suggests that ZHX1 may be a drug target or biomarker for diseases that are characterized by chronic inflammation.

In addition to its role in cell signaling and inflammation, ZHX1 has also been shown to play a role in the development and progression of several diseases. For example, ZHX1 has been shown to be involved in the development of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. It has also been shown to be involved in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. In addition, ZHX1 has been shown to be involved in the development of inflammatory diseases, such as heart disease and diabetes.

Given the role that ZHX1 plays in the regulation of cell signaling and inflammation, it is a potential drug target or biomarker for a wide range of diseases. For example, ZHX1 may be a potential drug target for neurodegenerative disorders, autoimmune diseases, and inflammatory diseases. It may also be a useful biomarker for tracking the progress of these diseases, as well as for identifying potential new treatments.

In conclusion, ZHX1 is a protein that is expressed in various tissues of the body that plays a role in cell signaling and inflammation. It has been shown to promote the growth and survival of certain cell types, while inhibiting the growth and survival of others. Its role in cell signaling and inflammation makes it a potential drug target or biomarker for a wide range of diseases. Further research is needed to fully understand the role of ZHX1 in disease development and to identify potential new treatments.

Protein Name: Zinc Fingers And Homeoboxes 1

Functions: Acts as a transcriptional repressor. Increases DNMT3B-mediated repressive transcriptional activity when DNMT3B is tethered to DNA. May link molecule between DNMT3B and other co-repressor proteins

The "ZHX1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZHX1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211